What changed
Clorox delivered a big Q1 FY27 beat, with adjusted EPS of $1.55 versus the $1.07 consensus — a $0.48 beat (+44.6%). Net sales rose 33.3% YoY to $1,905M, with the GOJO acquisition contributing about 15 points and organic sales up 18%, reflecting the lap of the prior-year ERP-related inventory drawdown. Management maintained its FY2027 adjusted EPS outlook of $5.70–$6.00 (GAAP $5.41–$5.71) but now expects results closer to the low end, citing a tougher cost environment with higher inflationary pressures.
Why it matters
Clorox delivered a big Q1 FY27 beat, with adjusted EPS of $1.55 versus the $1.07 consensus — a $0.48 beat (+44.6%). Net sales rose 33.3% YoY to $1,905M, with the GOJO acquisition contributing about 15